Conjunctival Melanoma Responsive to Combined Systemic BRAF/MEK Inhibitors
- PMID: 27893585
- DOI: 10.1097/IOP.0000000000000833
Conjunctival Melanoma Responsive to Combined Systemic BRAF/MEK Inhibitors
Abstract
This report demonstrates a unique case of conjunctival melanoma harboring a BRAF V600E mutation responsive to systemic therapy with BRAF and MEK inhibitors. While systemic therapy would not be appropriate in patients with local disease alone, it may act therapeutically in cases of higher stage ocular surface and eyelid melanoma.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
